Suppr超能文献

环境响应性阳离子纳米凝胶的细胞相容性、膜破坏和 siRNA 递释。

Cytocompatibility, membrane disruption, and siRNA delivery using environmentally responsive cationic nanogels.

机构信息

McKetta Department of Chemical Engineering, 200 E. Dean Keeton St. Stop C0400, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, 107 W Dean Keeton Street Stop C0800, Austin, TX 78712, USA.

McKetta Department of Chemical Engineering, 200 E. Dean Keeton St. Stop C0400, Austin, TX 78712, USA.

出版信息

J Control Release. 2021 Apr 10;332:608-619. doi: 10.1016/j.jconrel.2021.03.004. Epub 2021 Mar 3.

Abstract

Advances in the formulation of nucleic acid-based therapeutics have rendered them a promising avenue for treating diverse ailments. Nonetheless, clinical translation of these therapies is hindered by a lack of strategies to ensure the delivery of these nucleic acids in a safe, efficacious manner with the required spatial and temporal control. To this aim, environmentally responsive hydrogels are of interest due to their ability to provide the desired characteristics of a protective carrier for siRNA delivery. Previous work in our laboratory has demonstrated the ability to synthesize nanoparticle formulations with targeted pK, swelling, and surface PEG density. Here, a library of nanoparticle formulations was assessed on their in vitro toxicity, hemolytic capacity, siRNA loading, and gene-silencing efficacy. Successful candidates exhibited the lowest degrees of cytotoxicity, pH-dependent membrane disruption potential, the highest siRNA loading, and the highest transfection efficacies.

摘要

核酸治疗药物的不断发展,为治疗各种疾病提供了一条很有前途的途径。然而,这些疗法的临床转化受到缺乏策略的阻碍,无法以安全、有效的方式,在所需的空间和时间内控制这些核酸的传递。为此,环境响应水凝胶因其能够为 siRNA 传递提供所需的保护载体特性而受到关注。我们实验室之前的工作已经证明了能够合成具有靶向 pK、溶胀和表面 PEG 密度的纳米颗粒制剂的能力。在这里,对一组纳米颗粒制剂进行了体外毒性、溶血能力、siRNA 负载和基因沉默效果的评估。成功的候选物表现出最低的细胞毒性、pH 依赖性膜破坏潜力、最高的 siRNA 负载和最高的转染效率。

相似文献

4
Multifunctional nanogels for siRNA delivery.用于 siRNA 递送的多功能纳米凝胶。
Acc Chem Res. 2012 Jul 17;45(7):985-93. doi: 10.1021/ar200216f. Epub 2011 Dec 19.

引用本文的文献

3
In Situ Cocktail Nanovaccine for Cancer Immunotherapy.原位鸡尾酒纳米疫苗用于癌症免疫治疗。
Adv Sci (Weinh). 2023 Nov;10(31):e2207697. doi: 10.1002/advs.202207697. Epub 2023 Sep 22.
5
Oral delivery of RNAi for cancer therapy.癌症治疗的 RNAi 口服递送。
Cancer Metastasis Rev. 2023 Sep;42(3):699-724. doi: 10.1007/s10555-023-10099-x. Epub 2023 Mar 27.

本文引用的文献

1
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
5
Overcoming cellular barriers for RNA therapeutics.克服 RNA 治疗药物的细胞屏障。
Nat Biotechnol. 2017 Mar;35(3):222-229. doi: 10.1038/nbt.3802. Epub 2017 Feb 27.
6
The delivery of therapeutic oligonucleotides.治疗性寡核苷酸的递送
Nucleic Acids Res. 2016 Aug 19;44(14):6518-48. doi: 10.1093/nar/gkw236. Epub 2016 Apr 15.
8
Chemical and structural modifications of RNAi therapeutics.RNAi 治疗药物的化学和结构修饰。
Adv Drug Deliv Rev. 2016 Sep 1;104:16-28. doi: 10.1016/j.addr.2015.10.015. Epub 2015 Nov 5.
9
siRNA Versus miRNA as Therapeutics for Gene Silencing.作为基因沉默疗法的小干扰RNA与微小RNA
Mol Ther Nucleic Acids. 2015 Sep 15;4(9):e252. doi: 10.1038/mtna.2015.23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验